Company / SG&A Expense
HERON THERAPEUTICS, INC. /DE/ SG&A Expense History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$18.4M
FY2017
5-year range
$11.0M / $18.4M
FY2016-FY2017
Trend
+66.9%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$18M in FY2017.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, sg&a expense increased 66.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $18.4M | +66.9% |
| FY2016 | $11.0M | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026